Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory properties.
Palagummi
Priya
P
Drexel University College of Medicine, Philadelphia, Pa, USA.
Saltzman
Heath
H
Ezekowitz
Michael
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000378:metabolism / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D001384:Azetidines / Q000627:therapeutic use; D001596:Benzylamines; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000150:complications; D019934:International Normalized Ratio; D020521:Stroke / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D013917:Thrombin / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000378:metabolism / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran; D014859:Warfarin; D013917:Thrombin